137 related articles for article (PubMed ID: 10655270)
21. Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation.
O'Glasser AY; Scott DL; Corless CL; Zaman A; Sasaki A; Gopal DV; Rayhill SC; Orloff SL; Ham JM; Rabkin JM; Flora K; Davies CH; Broberg CS; Schwartz JM
Clin Transplant; 2010; 24(5):643-51. PubMed ID: 19925473
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance-associated hepatic iron overload.
Mendler MH; Turlin B; Moirand R; Jouanolle AM; Sapey T; Guyader D; Le Gall JY; Brissot P; David V; Deugnier Y
Gastroenterology; 1999 Nov; 117(5):1155-63. PubMed ID: 10535879
[TBL] [Abstract][Full Text] [Related]
23. The S65C mutation in Spain. Implications for iron overload screening.
Remacha AF; Barceló MJ; Sardà MP; Blesa I; Altés A; Baiget M
Haematologica; 2000 Dec; 85(12):1324-5. PubMed ID: 11114141
[TBL] [Abstract][Full Text] [Related]
24. Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.
Bonkovsky HL; Obando JV
Curr Gastroenterol Rep; 1999; 1(1):30-7. PubMed ID: 10980924
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
[TBL] [Abstract][Full Text] [Related]
26. Iron overload secondary to cirrhosis: a mimic of hereditary haemochromatosis?
Abu Rajab M; Guerin L; Lee P; Brown KE
Histopathology; 2014 Oct; 65(4):561-9. PubMed ID: 24635122
[TBL] [Abstract][Full Text] [Related]
27. Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure.
Fenton H; Torbenson M; Vivekanandan P; Yeh MM; Hart J; Ferrell L
Transplantation; 2009 Apr; 87(8):1256-60. PubMed ID: 19384175
[TBL] [Abstract][Full Text] [Related]
28. The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic stem cell transplantation.
Sucak GT; Yaşar DG; Yegin ZA; Ergün MA; Ozkurt ZN; Aki ŞZ; Güntekin S
Ann Hematol; 2012 Aug; 91(8):1281-7. PubMed ID: 22362121
[TBL] [Abstract][Full Text] [Related]
29. HFE gene mutations and Wilson's disease in Sardinia.
Sorbello O; Sini M; Civolani A; Demelia L
Dig Liver Dis; 2010 Mar; 42(3):216-9. PubMed ID: 19640812
[TBL] [Abstract][Full Text] [Related]
30. Non-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosis.
Noor MT; Tiwari M; Kumar R
Indian J Gastroenterol; 2016 Jan; 35(1):33-9. PubMed ID: 26873085
[TBL] [Abstract][Full Text] [Related]
31. HFE mutations in insulin resistance-associated hepatic iron overload.
Guillygomarc'h A; Mendler MH; Moirand R; Jouanolle AM; David V; Deugnier Y
J Hepatol; 2000 Sep; 33(3):515-6. PubMed ID: 11020014
[No Abstract] [Full Text] [Related]
32. Hemochromatosis in Ireland and HFE.
Ryan E; O'keane C; Crowe J
Blood Cells Mol Dis; 1998 Dec; 24(4):428-32. PubMed ID: 9851896
[TBL] [Abstract][Full Text] [Related]
33. HFE gene in primary and secondary hepatic iron overload.
Sebastiani G; Walker AP
World J Gastroenterol; 2007 Sep; 13(35):4673-89. PubMed ID: 17729389
[TBL] [Abstract][Full Text] [Related]
34. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
[No Abstract] [Full Text] [Related]
35. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
Byrnes V; Ryan E; O'Keane C; Crowe J
Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
37. Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overload.
Fargion S; Valenti L; Fracanzani AL
Hepatology; 2010 Apr; 51(4):1119-21. PubMed ID: 20373367
[No Abstract] [Full Text] [Related]
38. Iron overload and chronic hepatitis C: the role of HFE gene mutations.
García Buey L; González Mateos F
Rev Esp Enferm Dig; 2003 Dec; 95(12):819-28. PubMed ID: 14972003
[No Abstract] [Full Text] [Related]
39. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Loria P; Lonardo A; Carulli N
Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
[No Abstract] [Full Text] [Related]
40. Coexistence of HFE and rare UGT1A1 genes mutations in patients with iron overload related liver injury.
Sikorska K; Romanowski T; Stalke P; Jaskiewicz K; Bielawski KP
Adv Med Sci; 2010; 55(1):108-10. PubMed ID: 20371435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
